Oregon Administrative Rules
Chapter 332 - OREGON HEALTH AUTHORITY, HEALTH LICENSING OFFICE, BOARD OF DIRECT ENTRY MIDWIFERY
Division 26 - LEGEND DRUGS AND DEVICES
Section 332-026-0020 - Approved Legend Drugs For Neonatal Use
Universal Citation: OR Admin Rules 332-026-0020
Current through Register Vol. 63, No. 9, September 1, 2024
An LDM may administer the following legend drugs as approved by the Board for neonatal use:
(1) Eye Prophylaxis for disease of the newborn is limited to Erythromycin Ophthalmic (0.5%) Ointment (Ilotycin, AK-Mycin and generics).
(2) Prophylaxis for hemorrhagic disease of the newborn for oral use is limited to Mephyton.
(3) Prophylaxis for hemorrhagic disease of the newborn for intramuscular injection includes:
(a) AquaMephyton; and
(b) Konakion.
(4) Resuscitation is limited to medical oxygen.
Statutory/Other Authority: ORS 676.615 & ORS 687.493
Statutes/Other Implemented: ORS 687.493
Disclaimer: These regulations may not be the most recent version. Oregon may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
